CWM
CLB icon

Congress Wealth Management’s Core Laboratories CLB Stock Holding History

Congress Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-191,318
Closed -$3.88M – 844
2024
Q2 		$3.88M Buy
191,318
+8,036
+4% +$142K 0.06% 277
2024
Q1 		$3.13M Buy
183,282
+53,090
+41% +$835K 0.05% 269
2023
Q4 		$2.3M Sell
130,192
-22,954
-15% -$462K 0.04% 300
2023
Q3 		$3.68M Buy
153,146
+12,264
+9% +$301K 0.08% 247
2023
Q2 		$3.28M Buy
140,882
+5,202
+4% +$118K 0.08% 227
2023
Q1 		$2.99M Buy
135,680
+29,276
+28% +$685K 0.07% 233
2022
Q4 		$2.16M Sell
106,404
-15,823
-13% -$307K 0.06% 254
2022
Q3 		$1.65M Buy
122,227
+6,053
+5% +$102K 0.04% 289
2022
Q2 		$2.3M Sell
116,174
-915
-0.8% -$24.3K 0.06% 267
2022
Q1 		$3.71M Buy
+117,089
New +$3.28M 0.08% 242

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Congress Wealth Management's CLB Position: Q3 2024 in Review

Congress Wealth Management sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 191,318 shares — an estimated $3.88M sold.

Congress Wealth Management first reported a position in CLB in Q1 2022 and held it in 10 quarters. The position peaked at $3.88M in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Congress Wealth Management reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Congress Wealth Management sold 191,318 Core Laboratories shares in Q3 2024, an estimated $3.88M.
  • Congress Wealth Management first reported a position in Core Laboratories in Q1 2022 and held it in 10 quarters.
  • Congress Wealth Management's Core Laboratories position peaked at $3.88M in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Congress Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.